Early human drug trial halted after testing in healthy volunteers
NCT ID NCT06555601
Summary
This was the first study testing a new drug called UCB3101 in humans. Researchers gave single doses to healthy volunteers to check for safety and side effects. The study was terminated early, and the drug was not being tested to treat any specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UP0124 1
Edegem, Belgium
Conditions
Explore the condition pages connected to this study.